| MeSH term | MeSH ID | Detail |
|---|---|---|
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
Total
2
SCHEMBL62444
SCHEMBL62444 is a lipid of Polyketides (PK) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 584 references associated with SCHEMBL62444 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for SCHEMBL62444
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with SCHEMBL62444
NCBI Entrez Crosslinks
All references with SCHEMBL62444
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Roland WS et al. | Soy isoflavones and other isoflavonoids activate the human bitter taste receptors hTAS2R14 and hTAS2R39. | 2011 | J. Agric. Food Chem. | pmid:21942422 |
| Kim YS et al. | Characterization of a GH3 family β-glucosidase from Dictyoglomus turgidum and its application to the hydrolysis of isoflavone glycosides in spent coffee grounds. | 2011 | J. Agric. Food Chem. | pmid:21919440 |
| Ablajan K | A study of characteristic fragmentation of isoflavonoids by using negative ion ESI-MSn. | 2011 | J Mass Spectrom | pmid:21182215 |
| Baranowska I et al. | UHPLC method for the simultaneous determination of β-blockers, isoflavones and their metabolites in human urine. | 2011 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:21345747 |
| Van Poppel H and Tombal B | Chemoprevention of prostate cancer with nutrients and supplements. | 2011 | Cancer Manag Res | pmid:21629831 |
| Baranowska I and Magiera S | Analysis of isoflavones and flavonoids in human urine by UHPLC. | 2011 | Anal Bioanal Chem | pmid:20936271 |
| da Graça R Campos M and Matos MP | Bioactivity of isoflavones: assessment through a theoretical model as a way to obtain a "Theoretical Efficacy Related to Estradiol (TERE)". | 2010 | Int J Mol Sci | pmid:20386649 |
| Russo M et al. | Phytochemicals in cancer prevention and therapy: truth or dare? | 2010 | Toxins (Basel) | pmid:22069598 |
| Hsu A et al. | Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells. | 2010 | Exp. Biol. Med. (Maywood) | pmid:20404023 |
| Bawa S | The significance of soy protein and soy bioactive compounds in the prophylaxis and treatment of osteoporosis. | 2010 | J Osteoporos | pmid:20981338 |